Ally Chem Laboratories to expand its bulk drug unit at Focal Point in Derabassi in Patiala district of Punjab with an investment of Rs. 450 million. The expansion details of the new unit are as follows.
| Sr. No. | Existing Product | Production Capacity(TPA) |
| 1. | Thinner | 3000.0 |
| 2. | Recovery of solvent (by distillation process) | 3000.0 |
| 3. | Ethyl Sodium Hexonate 50% | 138.2 |
|
| Proposed bulk drugs ? Campaign products |
|
| 1. | Rabeorazole Sodium | 84.0 |
| 2. | Fexofenadine Hydrochoride | 48.0 |
| 3. | Azithromycin | 36.0 |
| 4 | Clopidogrelo Hydrogen Bisulfate | 36.0 |
| 5. | Nimesulide | 84.0 |
| 6. | Ofloxacin | 72.0 |
| 7. | Atorvastatin Calcium | 84.0 |
| 8. | Aceclofenac | 96.0 |
|
| Proposed By-Products from Bulk Drugs |
|
| 1. | Spent sulfuric acid (23 %) | 399.0 |
|
|
|
|
|
|
| 11,950 ₹ | 4950 ₹ | 4950 ₹ | 4950 ₹ | 3950 ₹ |
Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202 Mobile : 0-97898-37940 email : [email protected] Privacy Policy
